FEMSelect

Founded: 2012 • Age: 14 yrs
A minimally invasive surgical system for uterine prolapse is developed.

About FEMSelect

FEMSelect is a company founded in 2012. It operates as a HealthTech, and Direct-to-Consumer (D2C). FEMSelect has raised $9 million across 1 funding round from investors including New Age Ventures, Triventures and Robin Hood Ventures. FEMSelect offers products and services including EnPlace and Elitone. FEMSelect operates in a competitive market with competitors including Pharmiva, AVeta Medical, Bioceptive, Madorra and Aqueduct Medical, among others.

  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Femselect Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $9 M (USD)

    in 1 rounds

  • Latest Funding Round
    $9 M (USD), Series B

    Oct 19, 2022

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of FEMSelect

FEMSelect offers a comprehensive portfolio of products and services, including EnPlace and Elitone. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

A minimally invasive treatment for pelvic organ prolapse.

A device addressing pelvic floor health for women.

People of FEMSelect
Headcount 1-10
Employee Profiles 6
Employee Profiles
People
Renee Selman
Co-CEO
People
Debbie Garner
Co-CEO
People
Boaz Harari
Founder & VP, Research & Development
People
Michael Adomiak
Market Development Director

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of FEMSelect

FEMSelect has successfully raised a total of $9M through 1 strategic funding round. The most recent funding activity was a Series B round of $9 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series B — $9.0M
  • First Round

    (19 Oct 2022)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2022 Amount Series B - FEMSelect Valuation New Age Ventures , Triventures
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in FEMSelect

FEMSelect has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include New Age Ventures, Triventures and Robin Hood Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Venture capital-backed startup studio focused on deep tech, healthcare, AI, and multiple sectors
Founded Year Domain Location
Venture capital firm investing in early stage healthcare startups
Founded Year Domain Location
Early-stage investments are made in high-growth startups by this group.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by FEMSelect

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - FEMSelect

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Femselect Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of FEMSelect

FEMSelect operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmiva, AVeta Medical, Bioceptive, Madorra and Aqueduct Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of smart medical devices against bacterial vaginosis in women
domain founded_year HQ Location
Non-hormonal device for menopause symptoms is developed using wound-healing process.
domain founded_year HQ Location
Medical devices for gynecological procedures are developed.
domain founded_year HQ Location
Therapeutic device for vaginal atrophy and dryness treatment is provided.
domain founded_year HQ Location
Develops cervical dilator devices for intrauterine procedures.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Femselect

Frequently Asked Questions about FEMSelect

When was FEMSelect founded?

FEMSelect was founded in 2012 and raised its 1st funding round 10 years after it was founded.

Is FEMSelect a funded company?

FEMSelect is a funded company, having raised a total of $9M across 1 funding round to date. The company's 1st funding round was a Series B of $9M, raised on Oct 19, 2022.

What does FEMSelect do?

Solutions for womens pelvic health are developed by FEMSelect. The company specializes in minimally invasive treatments for pelvic organ prolapse, affecting millions of women globally. Products like EnPlace, an FDA-cleared same-day procedure, are offered to help women return to normal activities quickly. The focus is on innovative medical devices within the healthcare sector, targeting womens health challenges. Support for medical professionals and patients is provided through educational resources and specialist networks.

Who are the top competitors of FEMSelect?

FEMSelect's top competitors include Madorra, Bioceptive and AVeta Medical.

What products or services does FEMSelect offer?

FEMSelect offers EnPlace and Elitone.

Who are FEMSelect's investors?

FEMSelect has 9 investors. Key investors include New Age Ventures, Triventures, Robin Hood Ventures, Mid Atlantic Bio Angels, and MEDA Angels.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available